KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 63 filers reported holding KINNATE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $433,222 | -68.6% | 71,020 | -38.5% | 0.00% | -100.0% |
| Q3 2022 | $1,381,000 | -7.6% | 115,550 | -2.5% | 0.00% | 0.0% |
| Q2 2022 | $1,495,000 | +54.3% | 118,530 | +37.8% | 0.00% | +100.0% |
| Q1 2022 | $969,000 | -52.9% | 86,040 | -25.9% | 0.00% | -50.0% |
| Q4 2021 | $2,058,000 | -6.2% | 116,140 | +21.9% | 0.00% | 0.0% |
| Q3 2021 | $2,193,000 | -1.9% | 95,270 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $2,236,000 | -29.9% | 96,040 | -6.2% | 0.00% | -33.3% |
| Q1 2021 | $3,191,000 | -24.9% | 102,410 | -4.1% | 0.00% | -40.0% |
| Q4 2020 | $4,247,000 | – | 106,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $60,447,769 | 31.36% |
| Vida Ventures Advisors, LLC | 2,207,772 | $13,798,575 | 18.88% |
| Lynx1 Capital Management LP | 2,214,250 | $13,839,063 | 11.54% |
| Foresite Capital Management V, LLC | 1,975,001 | $12,343,756 | 9.12% |
| Nextech Invest Ltd. | 2,329,480 | $14,559,250 | 6.08% |
| Ally Bridge Group (NY) LLC | 109,393 | $683,706 | 0.90% |
| Orbimed Advisors | 5,143,629 | $32,147,681 | 0.63% |
| RA Capital Management | 4,264,144 | $26,650,900 | 0.60% |
| Novo Holdings A/S | 815,707 | $5,098,169 | 0.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $3,112,506 | 0.33% |